Malaria Treatment Market to Grow at a CAGR of 4.4% and projected to reach US$ 2,126.42 million by 2027 | Zydus Cadila, Ipca Laboratories, Advanz Pharmaceutical

According to our latest study on “Malaria Treatment Market Forecast to 2027 – COVID-19 Impact and Analysis – by Treatment Type, Route of Administration, and End User,” the market was valued at US$ 1,508.12 million in 2019 and is projected to reach US$ 2,126.42 million by 2027; it is expected to grow at a CAGR of 4.4% from 2020 to 2027. The report highlights the key factors driving the market growth and prominent players with their developments in the market.

Advanz Pharmaceutical, Ipca Laboratories Ltd, Zydus Cadila, Glenmark, Olympus Corporation, Abbott, Sun Pharmaceutical Industries Ltd, Sanofi, GlaxoSmithKline plc., Novartis AG, and TEVA PHARMACEUTICAL INDUSTRIES LTD are among the leading companies operating in the global malaria treatment market.

Request for sample PDF Copy at: https://www.theinsightpartners.com/sample/TIPRE00018229/?utm_source=OpenPR&utm_medium=10144

Malaria is a life-threatening infectious disease caused by the Plasmodium parasite. The high prevalence of malaria in low-income countries and increasing initiatives undertaken by governments globally are driving the malaria treatment market, and is also expected to foster the market growth during the forecast period. However, increasing resistance to antimalarial drugs is restricting the market growth.

In the early phase of the pandemic owing to the urgency for efficient COVID-19 treatment therapeutics, in April 2020, the European Medicines Agency started investigation of Chloroquine and hydroxychloroquine (antimalarial drugs) for their potential to treat COVID-19. This has led to the increase in demand of antimalarial drugs in the management of COVID-19.

As per the WHO, African region accounts for the highest share of the global malaria burden. As per the WHO, in 2019, the region accounted for around 94% of malaria cases and deaths. Also, six countries in the region accounted for half of all malaria deaths worldwide: Nigeria (23%), the Democratic Republic of the Congo (11%), United Republic of Tanzania (5%), Burkina Faso (4%), Mozambique (4%) and Niger (4%). Children and pregnant women are the most vulnerable group affected by malaria. In 2019, children accounted for 67% (274,000) of all malaria deaths worldwide. Apart from this, the increasing number of traveler malaria cases is also contributing to the demand for the treatment of malaria. Every year, thousands of people travel to malaria-affected region, which is expected to increase infection risk. Thus, the high prevalence of malaria, especially in developing and underdeveloped countries, is a prime factor for the market's growth.

Based on treatment type, the malaria treatment market is segmented into vaccine, diagnostic test, and antimalarial agents. The diagnostic test segment held the largest share of the market in 2019. The growth of this segment is ascribed to the demand for high-quality and cost-efficient diagnostic methods, and introduction of novel diagnostic techniques. Also, the governments in the Middle East and Africa are taking measures to help the patients, such as Sanofi’s digitization steps to control malaria through MOSKI kit awareness in children in malaria endemic countries are being successful in the malaria treatment market.

Based on route of administration, the malaria treatment market is segmented into oral and parenteral. The oral segment held a larger share of the market in 2019, and is estimated to register a higher CAGR during the forecast period. Low manufacturing cost of tablets, capsules, and other orally administered drugs is a driving factor for the growth of the malaria treatment market.

Malaria Treatment Market – by Treatment Type

Vaccine
Antimalarial Agents
Diagnostic Test
Malaria Treatment Market – by Route of Administration

Oral
Parenteral
Malaria Treatment Market – by End User

Hospitals
Specialty Clinics

Buy Single User License Report Copy @ https://www.theinsightpartners.com/buy/TIPRE00018229/?utm_source=OpenPR&utm_medium=10144

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense, Food & beverage, Chemical and Materials, Semiconductors. Etc.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.